Evidence map›Paper›PMID 41899544›Full record

ArticleCancers2026

Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer.

Melinda Lillesand, Marie Austdal, Jakub Mroz, Ivar Skaland, Einar Gudlaugsson, Florus C de Jong, Tahlita C M Zuiverloon, Kjersti Engan, Emiel A M Janssen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Melinda LillesandDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.ORCID 0000-0001-8898-1330
Marie AustdalSection for Biostatistics, Department of Research, Stavanger University Hospital, 4011 Stavanger, Norway.
Jakub MrozDepartment of Electrical Engineering and Computer Science, University of Stavanger, 4021 Stavanger, Norway.
Ivar SkalandDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.
Einar GudlaugssonDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.
Florus C de JongDepartment of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0001-6853-5982
Tahlita C M ZuiverloonDepartment of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
Kjersti EnganDepartment of Electrical Engineering and Computer Science, University of Stavanger, 4021 Stavanger, Norway.ORCID 0000-0002-8970-0067
Emiel A M JanssenDepartment of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.ORCID 0000-0002-7760-5396

Funding

Folke Hermansen Foundation F-12320-D10192Western Norway Regional Health Authority F-12593-D11698
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacillus Calmette–GuérinBCG response subtypesbiomarkershigh-risk non-muscle-invasive bladder cancerimaging mass cytometryprogressionrisk stratificationspatial proteomicstreatment responsetumor microenvironment

Identifiers

PMID41899544
PMCPMC13024979

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.